A Facebook friend posted a link this morning to an ACLU website broadcasting a New York Federal court ruling that corporations can’t patent a gene that switches off cancer cells. The ACLU reporter writes: “Patents on genes associated with hereditary breast and ovarian cancer are invalid, ruled a New York federal court today. The precedent-setting ruling marks the first time a court has found patents on genes unlawful and calls into question the validity of patents now held on approximately 2,000 human genes.”
Clearly there is big money to be made in such treatments, but in this case the scales came down on in favor of ordinary people, this time women, rather than letting this instance of gene patenting become the latest license to print money for big pharma. I can’t help but wonder if this will have any impact on little farmers and the deplorable practice of GMO-altered seed patenting.